Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JH.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JH.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JH.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JH.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JH.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JH.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
CK.1.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CK.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.1.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CK.1.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CK.1.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CK.1.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CK.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CK.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.34.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.34.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.34.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.34.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.34.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.34.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.34.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.34.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.2.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.2.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.2.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.2.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.2.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.2.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.2.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JK.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-10807.5South Korea
JK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JK.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-18511.4Germany
JK.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JK.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JK.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JK.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.21.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.21.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.21.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.21.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.21.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.21.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.21.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.21.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FP.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FP.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FP.2.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FP.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used